CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: Ptaquiloside
Accession: CHEBI:82527
browse the term
Definition: A glycoside that has formula C20H30O8.
Synonyms: related_synonym: Braxin C; Formula=C20H30O8; InChI=1S/C20H30O8/c1-9-6-20(28-17-15(25)14(24)13(23)11(8-21)27-17)7-10(2)19(4-5-19)18(3,26)16(20)12(9)22/h7,9,11,13-17,21,23-26H,4-6,8H2,1-3H3/t9-,11-,13-,14+,15-,16?,17+,18+,20-/m1/s1; InChIKey=GPHSJPVUEZFIDE-VGFVQWJBSA-N; SMILES=C[C@@H]1C[C@@]2(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C(C)C3(CC3)[C@@](C)(O)C2C1=O
xref: CAS:87625-62-5; KEGG:C19515
xref_mesh: MESH:C043680
G
Ablim3
actin binding LIM protein family, member 3
decreases expression
ISO
ptaquiloside results in decreased expression of ABLIM3 mRNA
CTD
PMID:23274088
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
G
Adam2
ADAM metallopeptidase domain 2
decreases expression
ISO
ptaquiloside results in decreased expression of ADAM2 mRNA
CTD
PMID:23274088
NCBI chr15:40,242,651...40,284,025
Ensembl chr15:40,242,783...40,283,952
G
Adgrv1
adhesion G protein-coupled receptor V1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of ADGRV1 mRNA
CTD
PMID:23274088
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
G
Adora3
adenosine A3 receptor
decreases expression
ISO
ptaquiloside results in decreased expression of ADORA3 mRNA
CTD
PMID:23274088
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
G
Aebp1
AE binding protein 1
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of AEBP1 mRNA ptaquiloside results in decreased expression of AEBP1 mRNA
CTD
PMID:23274088
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
G
Agtr1a
angiotensin II receptor, type 1a
decreases expression
ISO
ptaquiloside results in decreased expression of AGTR1A mRNA
CTD
PMID:23274088
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Ahrr
aryl-hydrocarbon receptor repressor
multiple interactions increases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in increased expression of AHRR mRNA ptaquiloside results in increased expression of AHRR mRNA
CTD
PMID:23274088
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
G
Amigo1
adhesion molecule with Ig like domain 1
decreases expression
ISO
ptaquiloside results in decreased expression of AMIGO1 mRNA
CTD
PMID:23274088
NCBI chr 2:195,823,138...195,828,593
Ensembl chr 2:195,823,042...195,829,585
G
Anxa5
annexin A5
affects expression
ISO
ptaquiloside affects the expression of ANXA5 protein
CTD
PMID:22143989
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Apoa1
apolipoprotein A1
decreases expression
ISO
ptaquiloside results in decreased expression of APOA1 mRNA
CTD
PMID:23274088
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Asic2
acid sensing ion channel subunit 2
decreases expression
ISO
ptaquiloside results in decreased expression of ASIC2 mRNA
CTD
PMID:23274088
NCBI chr10:65,870,592...66,940,577
Ensembl chr10:65,870,594...66,940,424
G
Atp8b3
ATPase phospholipid transporting 8B3
decreases expression
ISO
ptaquiloside results in decreased expression of ATP8B3 mRNA
CTD
PMID:23274088
NCBI chr 7:9,175,544...9,195,449
Ensembl chr 7:9,175,391...9,195,442
G
Bmp4
bone morphogenetic protein 4
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of BMP4 mRNA
CTD
PMID:23274088
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CACNA1C mRNA
CTD
PMID:23274088
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
G
Cacnb4
calcium voltage-gated channel auxiliary subunit beta 4
decreases expression
ISO
ptaquiloside results in decreased expression of CACNB4 mRNA
CTD
PMID:23274088
NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944
G
Ccl24
C-C motif chemokine ligand 24
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CCL24 mRNA
CTD
PMID:23274088
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccr4
C-C motif chemokine receptor 4
decreases expression
ISO
ptaquiloside results in decreased expression of CCR4 mRNA
CTD
PMID:23274088
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Cd226
CD226 molecule
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CD226 mRNA
CTD
PMID:23274088
NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051
G
Cd4
Cd4 molecule
decreases expression
ISO
ptaquiloside results in decreased expression of CD4 mRNA
CTD
PMID:23274088
NCBI chr 4:157,668,878...157,695,366
Ensembl chr 4:157,668,878...157,695,191
G
Cdh4
cadherin 4
decreases expression
ISO
ptaquiloside results in decreased expression of CDH4 mRNA
CTD
PMID:23274088
NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:166,525,099...167,003,371
G
Cdh8
cadherin 8
decreases expression
ISO
ptaquiloside results in decreased expression of CDH8 mRNA
CTD
PMID:23274088
NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,494,174...5,895,669
G
Chek1
checkpoint kinase 1
increases phosphorylation
ISO
ptaquiloside results in increased phosphorylation of CHEK1 protein
CTD
PMID:22143989
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Cidec
cell death-inducing DFFA-like effector c
decreases expression
ISO
ptaquiloside results in decreased expression of CIDEC mRNA
CTD
PMID:23274088
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
G
Cntnap2
contactin associated protein 2
decreases expression
ISO
ptaquiloside results in decreased expression of CNTNAP2 mRNA
CTD
PMID:23274088
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
G
Col11a1
collagen type XI alpha 1 chain
decreases expression
ISO
ptaquiloside results in decreased expression of COL11A1 mRNA
CTD
PMID:23274088
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
G
Col1a1
collagen type I alpha 1 chain
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL1A1 mRNA ptaquiloside results in decreased expression of COL1A1 mRNA
CTD
PMID:23274088
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col2a1
collagen type II alpha 1 chain
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL2A1 mRNA ptaquiloside results in decreased expression of COL2A1 mRNA
CTD
PMID:23274088
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Col6a2
collagen type VI alpha 2 chain
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL6A2 mRNA ptaquiloside results in decreased expression of COL6A2 mRNA
CTD
PMID:23274088
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Col9a1
collagen type IX alpha 1 chain
decreases expression
ISO
ptaquiloside results in decreased expression of COL9A1 mRNA
CTD
PMID:23274088
NCBI chr 9:26,585,034...26,668,222
Ensembl chr 9:26,585,034...26,668,213
G
Cplx3
complexin 3
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CPLX3 mRNA
CTD
PMID:23274088
NCBI chr 8:58,003,535...58,010,297
Ensembl chr 8:58,003,535...58,010,297
G
Creb3l4
cAMP responsive element binding protein 3-like 4
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CREB3L4 mRNA
CTD
PMID:23274088
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
G
Ddit3
DNA-damage inducible transcript 3
decreases expression
ISO
ptaquiloside results in decreased expression of DDIT3 mRNA
CTD
PMID:22143989
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dst
dystonin
decreases expression
ISO
ptaquiloside results in decreased expression of DST mRNA
CTD
PMID:23274088
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
G
Ebf1
EBF transcription factor 1
decreases expression
ISO
ptaquiloside results in decreased expression of EBF1 mRNA
CTD
PMID:23274088
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
G
Ednra
endothelin receptor type A
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of EDNRA mRNA
CTD
PMID:23274088
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
ptaquiloside results in decreased expression of EGFR mRNA
CTD
PMID:23274088
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr4
early growth response 4
increases expression
ISO
ptaquiloside results in increased expression of EGR4 mRNA
CTD
PMID:23274088
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
G
Faf1
Fas associated factor 1
decreases expression
ISO
ptaquiloside results in decreased expression of FAF1 mRNA
CTD
PMID:23274088
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
G
Fat1
FAT atypical cadherin 1
decreases expression
ISO
ptaquiloside results in decreased expression of FAT1 mRNA
CTD
PMID:23274088
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
G
Fat3
FAT atypical cadherin 3
decreases expression
ISO
ptaquiloside results in decreased expression of FAT3 mRNA
CTD
PMID:23274088
NCBI chr 8:12,691,470...13,274,336
Ensembl chr 8:12,694,019...13,273,135
G
Fermt1
FERM domain containing kindlin 1
decreases expression
ISO
ptaquiloside results in decreased expression of FERMT1 mRNA
CTD
PMID:23274088
NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:120,171,561...120,213,555
G
Fgf9
fibroblast growth factor 9
decreases expression
ISO
ptaquiloside results in decreased expression of FGF9 mRNA
CTD
PMID:23274088
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
G
Foxa2
forkhead box A2
decreases expression
ISO
ptaquiloside results in decreased expression of FOXA2 mRNA
CTD
PMID:23274088
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Fzd1
frizzled class receptor 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of FZD1 mRNA
CTD
PMID:23274088
NCBI chr 4:29,310,303...29,314,701
Ensembl chr 4:29,310,091...29,312,643 Ensembl chr 4:29,310,091...29,312,643
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
ptaquiloside results in increased expression of GADD45A mRNA
CTD
PMID:22143989
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gbx2
gastrulation brain homeobox 2
decreases expression multiple interactions
ISO
ptaquiloside results in decreased expression of GBX2 mRNA [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of GBX2 mRNA
CTD
PMID:23274088
NCBI chr 9:90,509,633...90,512,212
Ensembl chr 9:90,509,633...90,512,212
G
Ggt5
gamma-glutamyltransferase 5
decreases expression
ISO
ptaquiloside results in decreased expression of GGT5 mRNA
CTD
PMID:23274088
NCBI chr20:13,043,255...13,071,523
Ensembl chr20:13,043,257...13,071,450
G
Gli3
GLI family zinc finger 3
decreases expression
ISO
ptaquiloside results in decreased expression of GLI3 mRNA
CTD
PMID:23274088
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
G
Grem1
gremlin 1, DAN family BMP antagonist
decreases expression
ISO
ptaquiloside results in decreased expression of GREM1 mRNA
CTD
PMID:23274088
NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
G
Grid2
glutamate ionotropic receptor delta type subunit 2
decreases expression
ISO
ptaquiloside results in decreased expression of GRID2 mRNA
CTD
PMID:23274088
NCBI chr 4:92,415,019...93,892,472
Ensembl chr 4:92,415,230...93,889,355
G
Hgf
hepatocyte growth factor
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of HGF mRNA
CTD
PMID:23274088
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hic1
HIC ZBTB transcriptional repressor 1
increases expression multiple interactions
ISO
ptaquiloside results in increased expression of HIC1 mRNA [ptaquiloside co-treated with Sodium Selenite] results in increased expression of HIC1 mRNA
CTD
PMID:23274088
NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475
G
Hnf1a
HNF1 homeobox A
decreases expression
ISO
ptaquiloside results in decreased expression of HNF1A mRNA
CTD
PMID:23274088
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
G
Hoxb1
homeo box B1
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of HOXB1 mRNA ptaquiloside results in decreased expression of HOXB1 mRNA
CTD
PMID:23274088
NCBI chr10:81,331,507...81,332,928
Ensembl chr10:81,331,507...81,332,836
G
Igf1
insulin-like growth factor 1
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of IGF1 mRNA ptaquiloside results in decreased expression of IGF1 mRNA
CTD
PMID:23274088
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Ihh
Indian hedgehog signaling molecule
decreases expression
ISO
ptaquiloside results in decreased expression of IHH mRNA
CTD
PMID:23274088
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
G
Il20rb
interleukin 20 receptor subunit beta
decreases expression
ISO
ptaquiloside results in decreased expression of IL20RB mRNA
CTD
PMID:23274088
NCBI chr 8:100,979,085...101,010,829
Ensembl chr 8:100,980,383...101,009,942
G
Inha
inhibin subunit alpha
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of INHA mRNA
CTD
PMID:23274088
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Ins2
insulin 2
decreases expression
ISO
ptaquiloside results in decreased expression of INS2 mRNA
CTD
PMID:23274088
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Itgav
integrin subunit alpha V
decreases expression
ISO
ptaquiloside results in decreased expression of ITGAV mRNA
CTD
PMID:23274088
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Klf5
KLF transcription factor 5
decreases expression
ISO
ptaquiloside results in decreased expression of KLF5 mRNA
CTD
PMID:23274088
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Lama2
laminin subunit alpha 2
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of LAMA2 mRNA ptaquiloside results in decreased expression of LAMA2 mRNA
CTD
PMID:23274088
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
G
Lama4
laminin subunit alpha 4
decreases expression
ISO
ptaquiloside results in decreased expression of LAMA4 mRNA
CTD
PMID:23274088
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
G
Lep
leptin
decreases expression
ISO
ptaquiloside results in decreased expression of LEP mRNA
CTD
PMID:23274088
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lhx5
LIM homeobox 5
decreases expression multiple interactions
ISO
ptaquiloside results in decreased expression of LHX5 mRNA [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of LHX5 mRNA
CTD
PMID:23274088
NCBI chr12:36,126,186...36,134,625
Ensembl chr12:36,126,186...36,134,625
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
decreases expression
ISO
ptaquiloside results in decreased expression of LIN7A mRNA
CTD
PMID:23274088
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Lpp
LIM domain containing preferred translocation partner in lipoma
decreases expression
ISO
ptaquiloside results in decreased expression of LPP mRNA
CTD
PMID:23274088
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
G
Map2k6
mitogen-activated protein kinase kinase 6
decreases expression
ISO
ptaquiloside results in decreased expression of MAP2K6 mRNA
CTD
PMID:22143989
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Meis1
Meis homeobox 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MEIS1 mRNA
CTD
PMID:23274088
NCBI chr14:93,155,426...93,294,373
Ensembl chr14:93,155,419...93,294,265
G
Meis2
Meis homeobox 2
decreases expression
ISO
ptaquiloside results in decreased expression of MEIS2 mRNA
CTD
PMID:23274088
NCBI chr 3:102,742,904...102,944,833
Ensembl chr 3:102,742,900...102,949,696
G
Mitf
melanocyte inducing transcription factor
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MITF mRNA
CTD
PMID:23274088
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mki67
marker of proliferation Ki-67
increases expression
ISO
ptaquiloside results in increased expression of MKI67 mRNA
CTD
PMID:22143989
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MMP9 mRNA ptaquiloside results in decreased expression of MMP9 mRNA
CTD
PMID:23274088
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mt1
metallothionein 1
increases expression
ISO
ptaquiloside results in increased expression of MT1 mRNA; ptaquiloside results in increased expression of MT1 protein
CTD
PMID:23274088
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
increases expression
ISO
ptaquiloside results in increased expression of MT2 mRNA; ptaquiloside results in increased expression of MT2 protein
CTD
PMID:23274088
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Myf5
myogenic factor 5
decreases expression
ISO
ptaquiloside results in decreased expression of MYF5 mRNA
CTD
PMID:23274088
NCBI chr 7:42,802,946...42,806,177
Ensembl chr 7:42,802,946...42,806,177
G
Myod1
myogenic differentiation 1
decreases expression
ISO
ptaquiloside results in decreased expression of MYOD1 mRNA
CTD
PMID:23274088
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
G
Myog
myogenin
decreases expression
ISO
ptaquiloside results in decreased expression of MYOG mRNA
CTD
PMID:23274088
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Nbn
nibrin
decreases expression
ISO
ptaquiloside results in decreased expression of NBN mRNA
CTD
PMID:22143989
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
G
Ncam1
neural cell adhesion molecule 1
decreases expression
ISO
ptaquiloside results in decreased expression of NCAM1 mRNA
CTD
PMID:23274088
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Neo1
neogenin 1
decreases expression
ISO
ptaquiloside results in decreased expression of NEO1 mRNA
CTD
PMID:23274088
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
G
Nfib
nuclear factor I/B
decreases expression
ISO
ptaquiloside results in decreased expression of NFIB mRNA
CTD
PMID:23274088
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
G
Ngf
nerve growth factor
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NGF mRNA
CTD
PMID:23274088
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nlrp12
NLR family, pyrin domain containing 12
decreases expression
ISO
ptaquiloside results in decreased expression of NLRP12 mRNA
CTD
PMID:23274088
NCBI chr 1:65,932,610...65,969,873
Ensembl chr 1:65,932,595...65,960,934
G
Nrcam
neuronal cell adhesion molecule
decreases expression
ISO
ptaquiloside results in decreased expression of NRCAM mRNA
CTD
PMID:23274088
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
G
Nrg1
neuregulin 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in increased expression of NRG1 mRNA
CTD
PMID:23274088
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nrp1
neuropilin 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NRP1 mRNA
CTD
PMID:23274088
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nrxn1
neurexin 1
decreases expression
ISO
ptaquiloside results in decreased expression of NRXN1 mRNA
CTD
PMID:23274088
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NTRK2 mRNA ptaquiloside results in decreased expression of NTRK2 mRNA
CTD
PMID:23274088
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Olig2
oligodendrocyte transcription factor 2
increases expression
ISO
ptaquiloside results in increased expression of OLIG2 mRNA
CTD
PMID:23274088
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
G
Onecut2
one cut homeobox 2
decreases expression
ISO
ptaquiloside results in decreased expression of ONECUT2 mRNA
CTD
PMID:23274088
NCBI chr18:57,831,647...57,890,884
Ensembl chr18:57,832,111...57,879,629
G
P2rx1
purinergic receptor P2X 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of P2RX1 mRNA
CTD
PMID:23274088
NCBI chr10:57,618,586...57,633,648
Ensembl chr10:57,618,586...57,633,623
G
Pax3
paired box 3
decreases expression
ISO
ptaquiloside results in decreased expression of PAX3 mRNA
CTD
PMID:23274088
NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
G
Pcdh10
protocadherin 10
decreases expression
ISO
ptaquiloside results in decreased expression of PCDH10 mRNA
CTD
PMID:23274088
NCBI chr 2:128,617,212...128,683,354
Ensembl chr 2:128,617,174...128,677,190
G
Pcdh15
protocadherin related 15
decreases expression
ISO
ptaquiloside results in decreased expression of PCDH15 mRNA
CTD
PMID:23274088
NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,963,565...15,494,719
G
Pcdhb15
protocadherin beta 15
decreases expression
ISO
ptaquiloside results in decreased expression of PCDHB7 mRNA
CTD
PMID:23274088
NCBI chr18:29,178,869...29,183,847
Ensembl chr18:29,181,052...29,183,804
G
Pgm5
phosphoglucomutase 5
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of PGM5 mRNA
CTD
PMID:23274088
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of PPARA mRNA ptaquiloside results in decreased expression of PPARA mRNA
CTD
PMID:23274088
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Prox1
prospero homeobox 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of PROX1 mRNA
CTD
PMID:23274088
NCBI chr13:101,669,184...101,719,804
Ensembl chr13:101,669,184...101,711,183
G
Rad50
RAD50 double strand break repair protein
decreases expression
ISO
ptaquiloside results in decreased expression of RAD50 mRNA
CTD
PMID:22143989
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Rad51b
RAD51 paralog B
decreases expression
ISO
ptaquiloside results in decreased expression of RAD51B mRNA
CTD
PMID:22143989
NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
G
Rag1
recombination activating 1
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of RAG1 mRNA ptaquiloside results in decreased expression of RAG1 mRNA
CTD
PMID:23274088
NCBI chr 3:87,917,061...87,928,158
Ensembl chr 3:87,917,004...87,928,291
G
Ret
ret proto-oncogene
decreases expression
ISO
ptaquiloside results in decreased expression of RET mRNA
CTD
PMID:23274088
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
Sema3c
semaphorin 3C
decreases expression
ISO
ptaquiloside results in decreased expression of SEMA3C mRNA
CTD
PMID:23274088
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
G
Serping1
serpin family G member 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SERPING1 mRNA
CTD
PMID:23274088
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sesn1
sestrin 1
increases expression
ISO
ptaquiloside results in increased expression of SESN1 mRNA
CTD
PMID:22143989
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Slc38a11
solute carrier family 38, member 11
decreases expression
ISO
ptaquiloside results in decreased expression of SLC38A11 mRNA
CTD
PMID:23274088
NCBI chr 3:49,987,119...50,033,615
Ensembl chr 3:49,987,124...50,033,615
G
Slc6a18
solute carrier family 6 member 18
decreases expression
ISO
ptaquiloside results in decreased expression of SLC6A18 mRNA
CTD
PMID:23274088
NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925
G
Slc7a9
solute carrier family 7 member 9
decreases expression
ISO
ptaquiloside results in decreased expression of SLC7A9 mRNA
CTD
PMID:23274088
NCBI chr 1:88,109,517...88,132,653
Ensembl chr 1:88,110,644...88,132,641
G
Sox11
SRY-box transcription factor 11
decreases expression
ISO
ptaquiloside results in decreased expression of SOX11 mRNA
CTD
PMID:23274088
NCBI chr 6:44,008,333...44,010,354
Ensembl chr 6:44,008,340...44,010,354
G
Sox8
SRY-box transcription factor 8
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SOX8 mRNA
CTD
PMID:23274088
NCBI chr10:14,584,829...14,589,818
Ensembl chr10:14,584,829...14,589,818
G
Spon2
spondin 2
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SPON2 mRNA
CTD
PMID:23274088
NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996
G
Spp1
secreted phosphoprotein 1
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SPP1 mRNA
CTD
PMID:23274088
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Sv2a
synaptic vesicle glycoprotein 2a
decreases expression
ISO
ptaquiloside results in decreased expression of SV2A mRNA
CTD
PMID:23274088
NCBI chr 2:183,741,489...183,757,290
Ensembl chr 2:183,741,547...183,756,927
G
Sycp3
synaptonemal complex protein 3
increases expression
ISO
ptaquiloside results in increased expression of SYCP3 mRNA
CTD
PMID:23274088
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
G
Syn2
synapsin II
decreases expression
ISO
ptaquiloside results in decreased expression of SYN2 mRNA
CTD
PMID:23274088
NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192
G
Syt1
synaptotagmin 1
multiple interactions decreases expression
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of SYT1 mRNA ptaquiloside results in decreased expression of SYT1 mRNA
CTD
PMID:23274088
NCBI chr 7:43,813,204...44,358,020
Ensembl chr 7:43,815,785...44,357,803
G
Syt7
synaptotagmin 7
decreases expression
ISO
ptaquiloside results in decreased expression of SYT7 mRNA
CTD
PMID:23274088
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
G
Tbx20
T-box transcription factor 20
decreases expression
ISO
ptaquiloside results in decreased expression of TBX20 mRNA
CTD
PMID:23274088
NCBI chr 8:23,200,104...23,258,218
Ensembl chr 8:23,204,507...23,258,175
G
Tbx3
T-box transcription factor 3
decreases expression
ISO
ptaquiloside results in decreased expression of TBX3 mRNA
CTD
PMID:23274088
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
G
Tfap2e
transcription factor AP-2 epsilon
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of TFAP2E mRNA
CTD
PMID:23274088
NCBI chr 5:139,009,447...139,030,695
Ensembl chr 5:139,009,453...139,031,108
G
Tfb1m
transcription factor B1, mitochondrial
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in increased expression of TFB1M mRNA
CTD
PMID:23274088
NCBI chr 1:44,115,240...44,161,737
Ensembl chr 1:44,119,166...44,161,709
G
Thrb
thyroid hormone receptor beta
decreases expression
ISO
ptaquiloside results in decreased expression of THRB mRNA
CTD
PMID:23274088
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Tie1
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
decreases expression
ISO
ptaquiloside results in decreased expression of TIE1 mRNA
CTD
PMID:23274088
NCBI chr 5:132,000,013...132,019,658
Ensembl chr 5:132,000,015...132,019,592
G
Tnc
tenascin C
decreases expression
ISO
ptaquiloside results in decreased expression of TNC mRNA
CTD
PMID:23274088
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of TNF mRNA
CTD
PMID:23274088
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnxb
tenascin XB
decreases expression
ISO
ptaquiloside results in decreased expression of TNXB mRNA
CTD
PMID:23274088
G
Tp53
tumor protein p53
decreases expression increases expression
ISO
ptaquiloside results in decreased expression of TP53 mRNA ptaquiloside results in increased expression of TP53 mRNA; ptaquiloside results in increased expression of TP53 protein
CTD
PMID:22143989
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trpc4
transient receptor potential cation channel, subfamily C, member 4
decreases expression
ISO
ptaquiloside results in decreased expression of TRPC4 mRNA
CTD
PMID:23274088
NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768
G
Tsc22d3
TSC22 domain family, member 3
increases expression
ISO
ptaquiloside results in increased expression of TSC22D3 mRNA
CTD
PMID:23274088
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Unc13a
unc-13 homolog A
decreases expression
ISO
ptaquiloside results in decreased expression of UNC13A mRNA
CTD
PMID:23274088
NCBI chr16:18,333,910...18,381,813
Ensembl chr16:18,336,229...18,381,872
G
Vsx2
visual system homeobox 2
decreases expression
ISO
ptaquiloside results in decreased expression of VSX2 mRNA
CTD
PMID:23274088
NCBI chr 6:104,214,842...104,240,264
Ensembl chr 6:104,217,230...104,240,018
G
Wnt3
Wnt family member 3
multiple interactions
ISO
[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of WNT3 mRNA
CTD
PMID:23274088
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
increases expression
ISO
ptaquiloside results in increased expression of XPC mRNA
CTD
PMID:22143989
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
G
Xrcc2
X-ray repair cross complementing 2
increases expression
ISO
ptaquiloside results in increased expression of XRCC2 mRNA
CTD
PMID:23274088
NCBI chr 4:9,423,873...9,502,980
Ensembl chr 4:9,423,898...9,442,482
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all